The Ministry makes Official Information Act (OIA) responses available where the information is considered to be of public interest, and where there is no risk to the privacy of individuals. The names and contact details of requestors are removed before publication.
To find out more about making an OIA request, visit OIA requests, where you can make a request via the online tool. Alternatively you can email the OIA Services team.
Documents are usually available in Adobe PDF format only.
| Publication date | Response date | Details of the request | Download |
|---|---|---|---|
| 14 December 2023 | 13 November 2023 | Emergency powers in response to the COVID-19 outbreak | H2023032566 Response (pdf, 267 KB) |
| 29 November 2023 | 28 November 2023 | Provisional Consent to the Distribution of New Medicines | H2023032720 Response (pdf, 1 MB) |
| 29 November 2023 | 28 August 2023 | New medical school in Aotearoa New Zealand | H2023028723 Response (pdf, 19.2 MB) |
| 27 November 2023 | 23 November 2023 | Use of Te reo Māori | H2023032643 Response (pdf, 236 KB) |
| 21 November 2023 | 16 August 2023 | Key documents related to food environments, obesity, nutrition and alcohol | H2023027828 Response (pdf, 6.5 MB) |
| 21 November 2023 | 02 May 2023 | Manatū Hauora guidelines refresh | H2023023045 Response (pdf, 236 KB) |
| 14 November 2023 | 13 November 2023 | Emergency powers in response to the COVID-19 outbreak | H2023032566 Response (pdf, 267 KB) |
| 10 November 2023 | 09 November 2023 | Weight of imported verified Medical Cannabis flowers | H2023032352 Response (pdf, 724 KB) |
| 10 November 2023 | 08 November 2023 | Information regarding Pfizer COVID-19 vaccine DNA contamination | H2023032746 Response (pdf, 731 KB) |
| 10 November 2023 | 08 November 2023 | Information regarding the rights of asylum seekers to access health care | H2023032335 Response (pdf, 1 MB) |
| 02 November 2023 | 02 November 2023 | Number of medicinal cannabis packs sold monthly (May 2023 - September 2023) | H2023032360 Response (pdf, 1.3 MB) |
| 02 November 2023 | 30 October 2023 | Evidence brief on puberty blockers | H2023031263 Response (pdf, 6.6 MB) |
| 18 October 2023 | 13 October 2023 | Number of medicinal cannabis packs sold monthly (January 2020 - August 2023) | H2023031735 Response (pdf, 759 KB) |
| 21 September 2023 | 13 September 2023 | Information on Cipflox | H2023031430 Response (pdf, 177 KB) |
| 21 September 2023 | 17 August 2023 | Key documents relating setting limits on salt and sugar levels | H2023028274 Response (pdf, 15.7 MB) |
| 21 September 2023 | 27 July 2023 | Update on COVID-19 safety reports | H2023029281 Response (pdf, 109 KB) |
| 29 August 2023 | 28 July 2023 | Mask wearing requirements | H2023023743 Response (pdf, 3.2 MB) |
| 16 August 2023 | 16 March 2020 | Information relating to Ngā Hau e Whā | H2020000787 Response (pdf, 9.3 MB) |
| 28 July 2023 | 03 July 2023 | Number of packs of unapproved medicines containing cannabis (April 2023) | H2023026370 Response (pdf, 743 KB) |
| 26 July 2023 | 26 July 2023 | The Medicines Classification Committee | H201602927 response (pdf, 1.9 MB) |
| 30 June 2023 | 30 June 2023 | Aotearoa New Zealand’s membership to the World Health Organization (WHO) | H2023026387 Response (pdf, 306 KB) |
| 30 June 2023 | 30 June 2023 | Technical Advisory Group Minutes - 2021 |
H2023021776 (pdf, 1.5 MB) H2023021776 2 (pdf, 6.6 MB) |
| 30 June 2023 | 29 June 2023 | Information on Sandrena | H2023026446 Response (pdf, 2.5 MB) |
| 30 June 2023 | 29 June 2023 | Medsafe safety report #47 | H2023027666 Response (pdf, 153 KB) |
| 30 June 2023 | 26 June 2023 | Functional Neurological Disorder | H2023025970 Response (pdf, 190 KB) |
| 30 June 2023 | 26 June 2023 | Funding to Māori health providers | H202206862 Response (pdf, 268 KB) |
| 30 June 2023 | 23 June 2023 | Medicines Adverse Reactions Committee (MARC) | H2023025351 Response (pdf, 366 KB) |
| 30 June 2023 | 23 June 2023 | Winter Preparedness Plan | H2023025888 Response (pdf, 12 MB) |
| 30 June 2023 | 22 June 2023 | Public health risk assessments |
H2023025868 part 1 (pdf, 8.6 MB) H2023025868 part 2 (pdf, 8.7 MB) |
| 30 June 2023 | 21 June 2023 | International Health Regulations (IHR) | H2023026024 Response (pdf, 283 KB) |
| 30 June 2023 | 20 June 2023 | Adverse Events Following Immunisation (AEFI) and the Medical Warning System (MWS) | H2023025722 Response (pdf, 3.3 MB) |
| 30 June 2023 | 19 June 2023 | InsideOUT | H2023026885 Response (pdf, 272 KB) |
| 30 June 2023 | 14 June 2023 | New Zealand nursing workforce | H2023024130 Response (pdf, 2.4 MB) |
| 30 June 2023 | 13 June 2023 | Therapeutic Products Bill | H2023025335 Response (pdf, 164 KB) |
| 30 June 2023 | 12 June 2023 | Mental health funding | H2023025271 Response (pdf, 533 KB) |
| 30 June 2023 | 12 June 2023 | Women's Health Strategy | H2023025507 Response (pdf, 209 KB) |
| 30 June 2023 | 09 June 2023 | Medical abortions | H2023025079 Response (pdf, 130 KB) |
| 30 June 2023 | 07 June 2023 | Bodily integrity | H2023023555 Response (pdf, 21.4 MB) |
| 30 June 2023 | 07 June 2023 | Data on pharmacy openings and closures | H2023025783 Response (pdf, 1.3 MB) |
| 30 June 2023 | 06 June 2023 | COVID-19 prevalence survey |
H2023024384 Response (pdf, 348 KB) H2023024384 Documents (pdf, 8.2 MB) |
| 30 June 2023 | 06 June 2023 | Te Arai Cemetery | H2023023845 Response (pdf, 266 KB) |
| 30 June 2023 | 02 June 2023 | Pay disparity |
H2023024814 Response (pdf, 375 KB) H2023024814 Document (pdf, 1.2 MB) |
| 30 June 2023 | 01 June 2023 | Data on products containing cannabidiol (CBD) and tetrahydrocannabinol (THC) | H2023024780 Response (pdf, 924 KB) |
| 30 June 2023 | 01 June 2023 | Manatū Hauora proactive release policy | H2023024725 Response (pdf, 855 KB) |
| 30 June 2023 | 31 May 2023 | Hemp license renewal | H2023024599 Response (pdf, 324 KB) |
| 30 June 2023 | 31 May 2023 | mRNA technology and COVID-19 vaccine | H2023024576 Response (pdf, 247 KB) |
| 30 June 2023 | 25 May 2023 | Manatū Hauora employment data | H2023025506 Response (pdf, 959 KB) |
| 30 June 2023 | 12 May 2023 | Natural Health Products | H2023023504 Response (pdf, 220 KB) |
| 30 June 2023 | 10 May 2023 | Departmental spending on office space and stationary | H2023023345 Response (pdf, 6.4 MB) |
| 30 June 2023 | 10 May 2023 | Late term abortion | H2023023402 Response (pdf, 170 KB) |
| 30 June 2023 | 09 May 2023 | Medicines supplied under section 29 of the Medicines Act 1982 | H2023022739 Response (pdf, 1.2 MB) |
| 30 June 2023 | 05 May 2023 | Manatū Hauora health strategies | H2023022400 Response (pdf, 224 KB) |
| 30 June 2023 | 03 April 2023 | Medicines Assessment Advisory Committee (MAAC) members | H2023022835 Response (pdf, 139 KB) |
| 29 June 2023 | 21 April 2023 | Community water fluoridation | H2023022609 Response (pdf, 259 KB) |
| 29 June 2023 | 20 April 2023 | Employment at Manatū Hauora | H2023021444 Response (pdf, 4.8 MB) |
| 29 June 2023 | 18 April 2023 | Assisted Dying | H2023022127 Response (pdf, 156 KB) |
| 29 June 2023 | 18 April 2023 | COVID-19 vaccine safety and efficacy | H2023021507 Response (pdf, 248 KB) |
| 29 June 2023 | 06 April 2023 | Vitamin B12 | H2023022132 Response (pdf, 217 KB) |
| 29 June 2023 | 03 April 2023 | Health care services | H2023022126 Response (pdf, 933 KB) |
| 28 June 2023 | 28 June 2023 | Information regarding excess mortality | H2023020095 (pdf, 1 MB) |
| 28 June 2023 | 28 June 2023 | Data on cannabidiol & tetrahydrocannabinol products | H2023022515 (pdf, 213 KB) |
| 28 June 2023 | 28 June 2023 | Excess deaths associated with COVID-19 | H2023025899 Response (pdf, 199 KB) |
| 28 June 2023 | 14 April 2023 | Australia’s Therapeutic Goods Administration (TGA) | H2023021445 Response (pdf, 245 KB) |
| 28 June 2023 | 11 April 2023 | Specialist Vape Retailers (SVRs) | H2023021674 Response (pdf, 345 KB) |
| 28 June 2023 | 06 April 2023 | Vaping products | H2023020894 Response (pdf, 7.7 MB) |
| 28 June 2023 | 04 April 2023 | Attention Deficit Hyperactivity Disorder (ADHD) | H2023020115 Response (pdf, 6.3 MB) |
| 28 June 2023 | 04 April 2023 | Vaccine passports and vaccine mandates | H2023019859 Response (pdf, 5.9 MB) |
| 28 June 2023 | 03 April 2023 | Data on packs of unapproved medicines containing cannabis | H2023021428 Response (pdf, 715 KB) |
| 28 June 2023 | 03 April 2023 | Dietary supplementary recalls | H2023021529 Response (pdf, 166 KB) |
| 28 June 2023 | 30 March 2023 | Post abortion counselling | H2023021623 Response (pdf, 184 KB) |
| 28 June 2023 | 16 March 2023 | List of roles at Manatū Hauora | H2023021442 Response (pdf, 1.3 MB) |
| 15 June 2023 | 01 June 2023 | Providing health services for transgender people | H2023022501 Response (pdf, 5 MB) |
| 08 June 2023 | 08 June 2023 | COVID-19 Prevalence Survey |
H2023024384 2 (pdf, 352 KB) H2023024384 1 (pdf, 9.1 MB) |
| 01 June 2023 | 01 June 2023 | Puberty Blockers | H2023024782 Response (pdf, 216 KB) |
| 30 May 2023 | 24 May 2023 | Pfizer non-clinical evaluation report | H2023024241 Response (pdf, 2.8 MB) |
| 10 May 2023 | 08 February 2023 | 2022 meeting minutes of the COVID-19 Vaccine Technical Advisory Group (CV-TAG) | H2022017624 Response (pdf, 6.2 MB) |
| 03 May 2023 | 27 April 2023 | Information regarding puberty blockers | H2023022566 Response (pdf, 155 KB) |
| 27 April 2023 | 20 January 2023 | Information regarding COVID-19 data |
H2022017725 Response (pdf, 240 KB) H2022017725 Spreadsheet (xlsx, 31 KB) |
| 05 April 2023 | 08 March 2023 | Information about the maximum permitted concentration of nicotine salts | H2022017347 response (pdf, 26.9 MB) |
| 14 March 2023 | 13 March 2023 | Information regarding excess/all-cause mortality | H2023020120 response (pdf, 1.9 MB) |
| 14 March 2023 | 10 March 2023 | Information regarding the review of the Medicinal Cannabis Scheme | H2023020072 response (pdf, 816 KB) |
| 14 March 2023 | 10 March 2023 | Information related to the findings of the Cochrane study | H2023020535 response (pdf, 218 KB) |
| 14 March 2023 | 09 March 2023 | Information regarding adverse events following immunisation (AEFI) numbers | H2023021044 response (pdf, 178 KB) |
| 14 March 2023 | 09 March 2023 | Information regarding censorship on Manatū Hauora social media platforms | H2023020146 response (pdf, 252 KB) |
| 14 March 2023 | 09 March 2023 | Information regarding COVID-19 deaths | H2023019972 response (pdf, 867 KB) |
| 14 March 2023 | 09 March 2023 | Information regarding neurodiversity policies | H2023020114 response (pdf, 3.4 MB) |
| 14 March 2023 | 09 March 2023 | Information regarding the Medsafe's income and expenditure | H2023020015 response (pdf, 186 KB) |
| 14 March 2023 | 08 March 2023 | Information regarding rongoā Māori and the Therapeutic Products Bill | H2023019571 response (pdf, 1.5 MB) |
| 14 March 2023 | 08 March 2023 | Information regarding the budgets of Manatū Hauora and the Therapeutics Products Bill | H2023020136 response (pdf, 194 KB) |
| 14 March 2023 | 06 March 2023 | Information on deaths related to COVID-19 |
H2023019862 response (pdf, 214 KB) H2023019862 - Appendix 1 (xlsx, 21 KB) |
| 14 March 2023 | 06 March 2023 | Information regarding myocarditis in COVID-19 patients | H2023019062 response (pdf, 2.3 MB) |
| 14 March 2023 | 06 March 2023 | Information regarding psychoactive substance licences | H2023019601 response (pdf, 4.2 MB) |
| 07 March 2023 | 03 March 2023 | Information regarding conscientious objection and abortion | H2023020070 response (pdf, 182 KB) |
| 07 March 2023 | 03 March 2023 | Information regarding health reforms and new health entities | H2023019691 response (pdf, 247 KB) |
| 07 March 2023 | 03 March 2023 | Information regarding Manatū Hauora commitment to environmental sustainability | H2023019900 response (pdf, 1004 KB) |
| 07 March 2023 | 02 March 2023 | Information regarding diversity and inclusion at Manatū Hauora | H2023019801 response (pdf, 792 KB) |
| 07 March 2023 | 02 March 2023 | Information regarding the World Health Organization (WHO) pandemic treaty | H2023019923 response (pdf, 211 KB) |
| 07 March 2023 | 01 March 2023 | Information regarding red meat consumption | H2023019832 response (pdf, 215 KB) |
| 07 March 2023 | 28 February 2023 | Information regarding exemptions to vaccine mandates | H2023019241 response (pdf, 3 MB) |
| 07 March 2023 | 28 February 2023 | Information regarding the 2015 Elective Health Target cost benefit analysis | H2023019707 response (pdf, 1.1 MB) |
| 07 March 2023 | 27 February 2023 | Information regarding attention deficit hyperactivity disorder (ADHD) | H2023019935 response (pdf, 257 KB) |
| 07 March 2023 | 27 February 2023 | Information regarding mental health costs | H2023019752 response (pdf, 204 KB) |
| 07 March 2023 | 27 February 2023 | Information regarding the listing of Adverse Effects Following Immunisation (AEFI) case numbers | H2023020621 response (pdf, 207 KB) |
| 06 March 2023 | 03 March 2023 | Information regarding rongoā Māori and the Therapeutic Products Bill | H2023019574 response (pdf, 9.5 MB) |
| 27 February 2023 | 24 February 2023 | Information regarding community water fluoridation and fluoridation levels | H2023019906 response (pdf, 262 KB) |
| 27 February 2023 | 24 February 2023 | Information regarding Ernst & Young (EY) contracts | H2023019614 response (pdf, 275 KB) |
| 27 February 2023 | 24 February 2023 | Information regarding rongoā Māori and the Therapeutic Products Bill | H2023019575 response (pdf, 1.9 MB) |
| 27 February 2023 | 24 February 2023 | Information related to climate change | H2023020011 response (pdf, 5 MB) |
| 27 February 2023 | 24 February 2023 | Information related to pandemic plans | H2023020151 response (pdf, 251 KB) |
| 27 February 2023 | 23 February 2023 | Information on health sector ministerial appointed boards or committees | H2023019710 response (pdf, 224 KB) |
| 27 February 2023 | 23 February 2023 | Information regarding Environmental Health Officers Qualifications Regulations 1993 | H2023019425 response (pdf, 2.4 MB) |
| 27 February 2023 | 20 February 2023 | Information on water fluoridation | H2023019751 response (pdf, 200 KB) |
| 27 February 2023 | 25 January 2023 | Information related to Facebook's takedown portal | H2023018978 response (pdf, 241 KB) |
| 20 February 2023 | 17 February 2023 | Information regarding COVID-19 reinfection | H2023019427 response (pdf, 241 KB) |
| 20 February 2023 | 17 February 2023 | Information regarding Ivermectin | H2023019804 response (pdf, 2 MB) |
| 20 February 2023 | 17 February 2023 | Information regarding natural health products | H2023019499 response (pdf, 257 KB) |
| 20 February 2023 | 16 February 2023 | Information regarding metformin and nitrosamine impurities | H2023019058 response (pdf, 174 KB) |
| 20 February 2023 | 16 February 2023 | Information relating to medical abortions | H2022018711 response (pdf, 205 KB) |
| 16 February 2023 | 15 February 2023 | Information on complaints made to the Registrar of Assisted Dying | H2023019720 response (pdf, 1.3 MB) |
| 16 February 2023 | 15 February 2023 | Information on nominations and appointments to the Medical Council of NZ | H2023019661 response (pdf, 258 KB) |
| 16 February 2023 | 15 February 2023 | Information regarding assisted dying service data and reporting | H2023019911 response (pdf, 173 KB) |
| 16 February 2023 | 15 February 2023 | Information regarding the Mpox vaccine | H2023019666 response (pdf, 190 KB) |
| 16 February 2023 | 15 February 2023 | Information related to the COVID-19 and National Immunisation Programme research round | H2023019400 response (pdf, 788 KB) |
| 16 February 2023 | 15 February 2023 | Information related to the End of Life Choice Act | H2023019795 response (pdf, 179 KB) |
| 16 February 2023 | 14 February 2023 | Information regarding the sale of tobacco imports | H2023019423 response (pdf, 222 KB) |
| 16 February 2023 | 13 February 2023 | Information regarding dispensing of mifepristone and misoprostol | H2023019631 response (pdf, 166 KB) |
| 16 February 2023 | 13 February 2023 | Information regarding lead contamination | H2022018112 response (pdf, 10.2 MB) |
| 16 February 2023 | 13 February 2023 | Information regarding the abortion services annual report | H2023019870 response (pdf, 168 KB) |
| 16 February 2023 | 13 February 2023 | Information regarding the Therapeutic Products Bill and the Medicinal Cannabis Scheme | H2022018971 response (pdf, 229 KB) |
| 16 February 2023 | 13 February 2023 | Information relating to the Dental Council |
H2023019301 response (pdf, 173 KB) H2023020487 response (pdf, 173 KB) |
| 16 February 2023 | 10 February 2023 | Information regarding Group A Streptococcus | H2023019243 response (pdf, 282 KB) |
| 16 February 2023 | 10 February 2023 | Information regarding the End of Life Choice Act | H2023019318 response (pdf, 1.6 MB) |
| 16 February 2023 | 09 February 2023 | Information regarding the Medicines Adverse Reactions Committee | H2023019684 response (pdf, 201 KB) |
| 15 February 2023 | 15 February 2023 | Information regarding long COVID | H2023019340 response (pdf, 1.2 MB) |
| 13 February 2023 | 13 February 2023 | Information on COVID-19 and international arrivals from China | H2023019200 response (pdf, 5.4 MB) |
| 09 February 2023 | 08 February 2023 | Information regarding rongoā Māori and the Therapeutic Products Bill | H2023019049 response (pdf, 5 MB) |
| 09 February 2023 | 07 February 2023 | Information regarding adverse reactions to vaccinations during pregnancy | H2023019257 response (pdf, 172 KB) |
| 09 February 2023 | 07 February 2023 | Information regarding suicide prevention and social media | H2022018206 response (pdf, 2.8 MB) |
| 09 February 2023 | 07 February 2023 | Information regarding the World Health Organization’s (WHO) International Health Review Committee | H2022018844 response (pdf, 1.4 MB) |
| 09 February 2023 | 07 February 2023 | Information related to the Therapeutic Products Bill |
H2023019553 response (pdf, 230 KB) H2023019367 response (pdf, 229 KB) H2023019556 response (pdf, 210 KB) H2023019524 response (pdf, 267 KB) |
| 09 February 2023 | 31 January 2023 | Information regarding the COVID-19 vaccination | H2022018814 response (pdf, 172 KB) |
| 09 February 2023 | 31 January 2023 | Information related to a RFP to survey the illicit tobacco market | H2023019147 response (pdf, 1.9 MB) |
| 09 February 2023 | 30 January 2023 | Information regarding adult dental health care | H2022018202 response (pdf, 2.2 MB) |
| 09 February 2023 | 30 January 2023 | Information related to Facebook's 'takedown portal' | H2022018547 response (pdf, 263 KB) |
| 07 February 2023 | 07 February 2023 | Information regarding COVID-19 vaccine purchasing agreements | H2023019004 response (pdf, 170 KB) |
| 01 February 2023 | 27 January 2023 | Information regarding COVID-19 vaccine efficacy | H2022018675 response (pdf, 212 KB) |
| 01 February 2023 | 27 January 2023 | Information regarding emergency department waiting times |
H2022018291 response (pdf, 6.1 MB) H2022018291 - Appendix 2 (xlsx, 51 KB) |
| 01 February 2023 | 27 January 2023 | Information related to Principal Advisors at Manatū Hauora | H2023018988 response (pdf, 2.3 MB) |
| 01 February 2023 | 26 January 2023 | Information regarding drinking water data |
H2022018821 response (pdf, 228 KB) H2022018821 - Appendix 1 (xlsx, 245 KB) |
| 01 February 2023 | 25 January 2023 | Information regarding face masks | H2022018342 response (pdf, 277 KB) |
| 01 February 2023 | 24 January 2023 | Information regarding guidelines for COVID-19 vaccination of children | H2022018201 response (pdf, 225 KB) |
| 24 January 2023 | 18 January 2023 | Information related to the COVID-19 vaccine | H2022018490 response (pdf, 1.7 MB) |
| 24 January 2023 | 18 January 2023 | Information related to the International Health Regulations (IHR) | H2022015383 response (pdf, 23.5 MB) |
| 24 January 2023 | 17 January 2023 | Information on the COVID-19 vaccine, testing and response budget | H2022018361 response (pdf, 220 KB) |
| 24 January 2023 | 16 January 2023 | Information on Pfizer Cumulative Analysis Report of PF-07302048 | H2022018890 response (pdf, 194 KB) |
| 24 January 2023 | 16 January 2023 | Information on the classification of cannabidiol | H2022017633 response (pdf, 178 KB) |
| 24 January 2023 | 16 January 2023 | Information on the Focus Group meetings for NEAC |
H2022017383 response (pdf, 8 MB) H2022017383 follow up response (pdf, 172 KB) H2022019313 response (pdf, 1 MB) |
| 24 January 2023 | 16 January 2023 | Information regarding staffing at Manatū Hauora | H2022017774 response (pdf, 234 KB) |
| 24 January 2023 | 30 November 2022 | Information on the regulatory impact statement on regulating natural health products |
H2022016152 response (pdf, 211 KB) H2022017883 response (pdf, 2.2 MB) H2022017883 follow up response (pdf, 222 KB) |
| 16 January 2023 | 13 January 2023 | Information on cannabidiol & tetrahydrocannabinol products | H2022017793 response (pdf, 196 KB) |
| 16 January 2023 | 13 January 2023 | Information on end-of-year functions at Manatū Hauora | H2022017746 response (pdf, 255 KB) |
| 16 January 2023 | 12 January 2023 | Information on social media management at Manatū Hauora | H2022017765 response (pdf, 203 KB) |
| 16 January 2023 | 12 January 2023 | Information regarding the Pfizer COVID-19 vaccine | H2022018097 response (pdf, 177 KB) |
| 16 January 2023 | 12 January 2023 | Information relating to antimicrobial resistance in fungal organisms | H2022017744 response (pdf, 232 KB) |
| 16 January 2023 | 11 January 2023 | Information on the communications team at Manatū Hauora | H2022017745 response (pdf, 218 KB) |
| 16 January 2023 | 11 January 2023 | Information regarding amendments to the Mental Health Act | H2022017874 response (pdf, 2.4 MB) |
| 16 January 2023 | 11 January 2023 | Information regarding the Pfizer COVID-19 vaccine | H2022018695 response (pdf, 143 KB) |
| 16 January 2023 | 09 January 2023 | Information regarding psychoactive substance licenses | H2022017627 response (pdf, 177 KB) |
| 16 January 2023 | 23 December 2022 | Information on working from home policy at Manatū Hauora | H2022017741 response (pdf, 225 KB) |
| 16 January 2023 | 23 December 2022 | Information regarding Manatū Hauora employee statistics | H2022017605 response (pdf, 296 KB) |